browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Amendment · 2026

Filing UUID
6ef5f4d1-8580-4737-9874-137bce974186
Type
1A — 1st Quarter - Amendment
Period
first_quarter
Year
2026
Posted
2026-04-23 20:26:42
Income (reported)
—
Expenses (reported)
$580,000
Expenses method
C
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

PHILIPS HOLDING USA, INC.

Manufacturing

Contact
ELIZABETH SHARP
Phone
+1 202-940-5631
Address
zip:02141, city:Cambridge, state:MA, street:222 Jacobs Street

Client

PHILIPS HOLDING USA INC.

State
MA
Country
US
Government-entity client
false
Effective date
2009-04-02

Issues lobbied + lobbyists

VET — Veterans

U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

DEF — Defense

FY2027 National Defense Authorization Act - Right to repair provisions Telehealth in DOD

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

CHM — Chemicals/Chemical Industry

EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES

TAR — Tariff (miscellaneous tariff bills)

Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.

Lobbyists:

Government entities lobbied: Council of Economic Advisers (CEA); HOUSE OF REPRESENTATIVES; SENATE

TAX — Taxation/Internal Revenue Code

Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HOM — Homeland Security

S. 2983, Protecting America from Cyberthreats Act, all provisions

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform Extension of Medicare telehealth waivers - H.R. 5081/S. 2709 - The Telehealth Modernization Act (all sections) S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act - whole bill

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof

Lobbyists:

Government entities lobbied: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

BUD — Budget/Appropriations

FY 2027 Veterans Affairs Appropriations, in general with some focus on telehealth provisions FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.